Physician profile
Layan Zhang
NPI 1801209887
$672.26
in general payments reported to CMS, 2019-2025
9 companies · $89.45 in 2025
The $89.45 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.31 · 2023: $92.00 · 2024: $397 · 2025: $89.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $125.00 | 2024 | Vemlidy |
| Noven Pharmaceuticals, INC. | $124.99 | 2024 | Xelstrym |
| E.R. Squibb & Sons, L.L.C. | $89.45 | 2025 | Cobenfy |
| Eisai INC. | $82.36 | 2024 | |
| Sunovion Pharmaceuticals INC. | $79.73 | 2022 | |
| Abbvie INC. | $67.09 | 2022-2023 | Vraylar |
| Noven Therapeutics, LLC | $50.64 | 2024 | Xelstrym, Secuado |
| Tris Pharma INC | $34.52 | 2023-2024 | Dyanavel Xr |
| Avion Pharmaceuticals | $18.48 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Layan Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.